Inactive Matrix Gla Protein (dp-ucMGP)—the dephosphorylated-uncarboxylated form of the vitamin K–dependent MGP—serves as a sensitive biomarker of functional vitamin K deficiency and vascular calcification risk, with clinical relevance across CKD/dialysis, cardiovascular disease, diabetes, and the bone–vascular axis. At Southern Medical Supplies Limited (SMSL), we offer serum/plasma dp-ucMGP measurement via ELISA and chemiluminescent immunoassays, with optional reflex panels (e.g., vitamin K1 (phylloquinone), PIVKA-II (DCP), osteocalcin, P1NP/CTX, calcium–phosphate, PTH, hs-CRP) to refine risk stratification, guide vitamin K repletion strategies or therapy adjustments (including VKA exposure), and monitor longitudinal outcomes. Our portfolio is sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the analytical sensitivity, traceability, and reproducibility clinicians need for confident decision-making.